BiotechTube

MK0869, aprepitant + Comparator: ondansetron IV

Phase 3Completed
1 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Postoperative Nausea and Vomiting

Conditions

Postoperative Nausea and Vomiting

Trial Timeline

May 13, 2004 → Apr 20, 2005

NCT ID
NCT00090246

About MK0869, aprepitant + Comparator: ondansetron IV

MK0869, aprepitant + Comparator: ondansetron IV is a phase 3 stage product being developed by Merck for Postoperative Nausea and Vomiting. The current trial status is completed. This product is registered under clinical trial identifier NCT00090246. Target conditions include Postoperative Nausea and Vomiting.

What happened to similar drugs?

20 of 20 similar drugs in Postoperative Nausea and Vomiting were approved

Approved (20) Terminated (3) Active (0)
✅Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVEisaiApproved
✅EsomeprazoleAstraZenecaApproved
✅Aprepitant, Dexamethasone, Ondansetron + Aprepitant, Dexamethasone, PlaceboMerckApproved
✅Sugammadex + NeostigmineMerckApproved
✅Aprepitant + Dexamethasone + Ondansetron + DexamethasoneMerckApproved
✅Suvorexant + PlaceboMerckApproved
✅Aprepitant plus Ondansetron + Ondansetron plus placeboMerckApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT00090246Phase 3Completed
NCT00090155Phase 3Completed

Competing Products

20 competing products in Postoperative Nausea and Vomiting

See all competitors
ProductCompanyStageHype Score
Naldemedine + PlaceboShionogiPhase 2
27
Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVEisaiApproved
43
Lemborexant 5 mg + Control (placebo) groupEisaiPhase 2
42
Ondansetron + PalonosetronEisaiPhase 2
35
AQUAVAN (fospropofol disodium; GPI 15715 )EisaiPhase 2
35
ONO-1101Ono PharmaceuticalPhase 2
35
ONO-1101Ono PharmaceuticalPhase 2/3
38
Levofloxacin Ophthalmic + CefuroximeSanten PharmaceuticalPhase 1/2
28
Levofloxacin Ophthalmic Product + Moxifloxacin Ophthalmic SolutionSanten PharmaceuticalPhase 1/2
28
Bupivacaine Liposome Injection T preparation + Bupivacaine Liposome Injection R preparationJiangsu Hengrui MedicinePhase 1
29
SHR0410 Injection + SHR0410 Injection + PlaceboJiangsu Hengrui MedicinePhase 3
36
SHR8554 InjectionJiangsu Hengrui MedicinePhase 1
29
EsomeprazoleAstraZenecaApproved
43
deep neuromuscular blockMerckPre-clinical
26
Rolapitant Dose 1 + Rolapitant Dose 2 + Rolapitant Dose 3 + Rolapitant Dose 4 + Ondansetron + PlaceboMerckPhase 2
35
MK0966, rofecoxib + Comparator: valdecoxibMerckPhase 3
40
Aprepitant, Dexamethasone, Ondansetron + Aprepitant, Dexamethasone, PlaceboMerckApproved
43
MK0719MerckPhase 2
27
Sugammadex + NeostigmineMerckApproved
43
MK0869, aprepitant + Comparator: ondansetron IVMerckPhase 3
40